In India, hundreds of people took the streets today to protest a US drug company’s attempt to patent a popular drug used by millions of people to treat the HIV virus. The company, Gilead Science, wants the Indian government to recognize its patent claim to the anti-retroviral drug TDF. Activists say the patent will make drugs like TDF inaccessible to thousands of people who could only afford a generic version. “We are protesting against the patent on anti retroviral drugs, HIV drugs because if it is patented the price will shoot up and we won’t be able to afford them and then we are going to die, it is a matter of life and death,” said Loon Gangte from The Indian Network Of People Living with HIV/AIDS.